Deep Track Capital
3 rounds tracked since 17 June 2026.
- Rounds
- 3
- Led
- 0
- Capital in these rounds
- $187M
Sectors
Countries
Rounds
- Superluminal MedicinesDevelops small-molecule medicines targeting GPCRs and metabolic diseases $60MSeries B · 3 Sept
- Oblenio BioDevelops therapies intended to treat autoimmune diseases. $62MSeries B · 27 Jun
- Triveni BioDevelops novel antibody treatments for immunological and inflammatory disorders, including atopic dermatitis. $65MSeries C · 17 Jun
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise